Aug 11 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2021 Jun 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.03 3.22 15.20
(-28.4 pct)
Operating loss 387 mln loss 309 mln 670 mln
Recurring loss 387 mln loss 308 mln 670 mln
Net loss 275 mln loss 195 mln 540 mln
EPS loss 72.97 yen loss 51.61 yen 142.80 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T